Steffi Oesterreich Selected Research

Steffi Oesterreich Research Topics

Disease

112	Breast Neoplasms (Breast Cancer) 03/2024 - 04/2003
86	Neoplasms (Cancer) 03/2024 - 04/2003
17	Lobular Carcinoma 02/2024 - 06/2013
15	Neoplasm Metastasis (Metastasis) 03/2024 - 09/2012
10	Carcinogenesis 05/2022 - 10/2006
6	Ovarian Neoplasms (Ovarian Cancer) 12/2018 - 12/2012
5	Triple Negative Breast Neoplasms 01/2023 - 06/2013
4	Brain Neoplasms (Brain Tumor) 01/2022 - 03/2016
3	Ductal Carcinoma 11/2018 - 03/2014
2	Disease Progression 01/2021 - 12/2016
2	Dwarfism 03/2009 - 04/2005
1	Carcinoma (Carcinomatosis) 07/2023
1	Inflammation (Inflammations) 01/2022
1	Secretory breast carcinoma 01/2022
1	Malignant Pleural Effusion 01/2022
1	Adenoid Cystic Carcinoma (Cylindroma) 01/2022
1	Pain (Aches) 08/2021
1	Spontaneous Fractures (Pathological Fracture) 08/2021
1	Starvation 01/2021
1	Brain Diseases (Brain Disorder) 11/2020

Drug/Important Bio-Agent (IBA)

55	Estrogen ReceptorsIBA 03/2024 - 05/2003
25	Estrogens (Estrogen)FDA Link 03/2024 - 09/2003
22	Hormones (Hormone)IBA 12/2023 - 04/2003
21	Proteins (Proteins, Gene)FDA Link 03/2024 - 04/2003
14	Estrogen Receptor alphaIBA 03/2024 - 06/2010
12	Cadherins (E-Cadherin)IBA 02/2024 - 09/2003
12	LigandsIBA 12/2023 - 01/2017
11	RNA (Ribonucleic Acid)IBA 03/2024 - 11/2016
10	DNA (Deoxyribonucleic Acid)IBA 09/2023 - 06/2012
9	Aromatase InhibitorsIBA 03/2024 - 04/2013
8	Messenger RNA (mRNA)IBA 03/2024 - 04/2003
8	Biomarkers (Surrogate Marker)IBA 09/2023 - 06/2013
7	Tamoxifen FDA LinkGeneric 09/2023 - 06/2010
6	Phenobarbital (Luminal)FDA Link 09/2023 - 10/2016
6	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 04/2003
6	Co-Repressor ProteinsIBA 11/2012 - 05/2003
5	Estradiol (Delestrogen)FDA LinkGeneric 09/2023 - 02/2012
5	ChromatinIBA 01/2023 - 02/2010
5	Lysine (L-Lysine)FDA Link 01/2019 - 06/2013
4	Histones (Histone)IBA 01/2023 - 07/2014
4	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2021 - 12/2009
4	Letrozole (Femara)FDA LinkGeneric 09/2017 - 04/2013
4	Insulin-Like Growth Factor I (IGF-1)IBA 02/2012 - 04/2003
3	Fulvestrant (Faslodex)FDA Link 03/2024 - 01/2023
3	SteroidsIBA 01/2021 - 12/2012
3	CarcinogensIBA 01/2020 - 03/2010
3	Insulin-Like PeptidesIBA 10/2018 - 04/2005
3	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 06/2013
3	Cell-Free Nucleic AcidsIBA 09/2017 - 03/2016
3	exemestane (Aromasin)FDA Link 03/2016 - 04/2013
2	Phosphotransferases (Kinase)IBA 01/2023 - 01/2022
2	B7-H1 AntigenIBA 01/2023 - 01/2019
2	ChemokinesIBA 01/2023 - 01/2019
2	Angiotensin IIIBA 03/2022 - 01/2018
2	Protein Isoforms (Isoforms)IBA 01/2022 - 06/2011
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 01/2020
2	Selective Estrogen Receptor Modulators (SERM)IBA 01/2021 - 01/2020
2	sulforaphaneIBA 07/2020 - 01/2018
2	Histone Deacetylase InhibitorsIBA 01/2018 - 06/2013
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2018 - 06/2013
2	Estrogen Receptor Modulators (Antiestrogen)IBA 10/2017 - 11/2012
2	Small Interfering RNA (siRNA)IBA 10/2017 - 07/2014
2	ParaffinIBA 01/2017 - 10/2016
2	Formaldehyde (Formol)FDA Link 01/2017 - 10/2016
2	Progestins (Progestagens)IBA 06/2013 - 12/2012
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2023
1	GlucocorticoidsIBA 01/2023
1	ElementsIBA 01/2023
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2023
1	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2023
1	CytokinesIBA 01/2023
1	Thrombin FDA Link 03/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 03/2022
1	ClaudinsIBA 03/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Serine (L-Serine)FDA Link 01/2022
1	Threonine (L-Threonine)FDA Link 01/2022
1	PlatinumIBA 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	Neuropilin-1IBA 01/2022
1	veliparibIBA 01/2022
1	Neuropilin-2IBA 01/2022
1	Small Cytoplasmic RNAIBA 01/2022
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 10/2021
1	Bone Density Conservation AgentsIBA 08/2021
1	ElectrolytesIBA 08/2021
1	Amino Acids FDA Link 01/2021
1	Waste Products (Waste Product)IBA 01/2021
1	Chitinase-3-Like Protein 1IBA 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2021
1	Steroid Receptors (Steroid Receptor)IBA 01/2021
1	Peptides (Polypeptides)IBA 11/2020

Therapy/Procedure

49	Therapeutics 03/2024 - 04/2003
7	Immunotherapy 01/2023 - 02/2010
5	Precision Medicine 01/2024 - 03/2017
2	Radiotherapy 08/2021 - 01/2021
2	Drug Therapy (Chemotherapy) 08/2021 - 01/2020
1	Continuity of Patient Care 01/2022
1	Aftercare (After-Treatment) 06/2021